Clinical Trials Browser

Phase 2 × Breast Neoplasms × Estramustine × Clear all

NCT02866955 2020-03-09

EFESE

Phase 2 Completed

Breast Neoplasms, Neoplasm Metastasis

NCT02853071 2019-11-18

BEST

Phase 2 Withdrawn

Breast Neoplasms

NCT00003066 2014-01-06

Docetaxel Combined With Estramustine in Treating Women With Metastatic Breast Cancer

Phase 2 Unknown

Breast Neoplasms